1. Home
  2. KORE vs LEXX Comparison

KORE vs LEXX Comparison

Compare KORE & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORE Group Holdings Inc.

KORE

KORE Group Holdings Inc.

HOLD

Current Price

$4.80

Market Cap

78.9M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.66

Market Cap

16.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KORE
LEXX
Founded
2003
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.9M
16.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KORE
LEXX
Price
$4.80
$0.66
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$1.50
AVG Volume (30 Days)
40.3K
1.5M
Earning Date
11-12-2025
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$285,408,000.00
$705,923.00
Revenue This Year
$1.26
$13.35
Revenue Next Year
$7.55
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
0.06
52.05
52 Week Low
$1.66
$0.46
52 Week High
$4.88
$2.43

Technical Indicators

Market Signals
Indicator
KORE
LEXX
Relative Strength Index (RSI) 63.55 42.15
Support Level $4.16 $0.46
Resistance Level $4.50 $0.72
Average True Range (ATR) 0.25 0.11
MACD 0.01 0.00
Stochastic Oscillator 90.67 49.34

Price Performance

Historical Comparison
KORE
LEXX

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: